Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;21(1):24-33.
doi: 10.1002/jcla.20159.

Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease

Affiliations

Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease

Susanna Levy et al. J Clin Lab Anal. 2007.

Abstract

A specific and reliable competitive affinity assay kit has been developed to quantitatively measure neural thread protein (NTP) in first morning urine samples. This assay, called the urine neural thread protein test (UNTP), is a competitive enzyme-linked immunosorbent assay (ELISA) format affinity assay using 32-well microtiter plates. The assay detects UNTP in the 10-60 microg/mL range (an improvement over earlier assays of 10(3) x ), is linear and more reproducible (average coefficient of variation [CV] 6.2% in precision studies). The utility of the assay has been demonstrated in urine samples from patients with Alzheimer's disease (AD) and controls (sensitivity of 90% and specificity of 91%). Test-retest assays of subjects with AD and controls were comparatively stable at intervals of 2 days to 4.5 years, which suggests that positive (elevated) or negative (normal) NTP levels do not fluctuate significantly over time with respect to the cutoff.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 Census. Arch Neurol 2003;60:1119–1122. - PubMed
    1. Cummings JL. Alzheimer's disease. N Engl J Med 2004;351:56–67. - PubMed
    1. Jorst BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc 1995;43:1248–1255. - PubMed
    1. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein EE4 association with dementia in a population‐based study: the Framingham study. Neurology 1996;46:673–677. - PubMed
    1. Pirtilla T, Kim KS, Mehta PD, et al. Soluble amyloid‐β‐protein in the cerebrospinal fluid of patients with Alzheimer's disease, vascular dementia and controls. J Neurol Sci 1994;127:90–95. - PubMed

Publication types

Substances